Latest Articles
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer - cancernetwork.com
Selinexor Misses PFS End Point in TP53 Wild-Type Endometrial Cancer cancernetwork.com
Published: July 31, 2026, 2:37 p.m.
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged - TipRanks
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged TipRanks
Published: July 31, 2026, 2:09 p.m.
Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis - Fierce Pharma
Xpovio mulligan in endometrial cancer comes up short as Karyopharm presses on in myelofibrosis Fierce Pharma
Published: July 31, 2026, 2 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance Canada
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Yahoo! Finance Canada
Published: July 31, 2026, 1:24 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - ca.finance.yahoo.com
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix ca.finance.yahoo.com
Published: July 31, 2026, 1:24 p.m.
Endometriosis musical set for Edinburgh Fringe stage - FemTech World
Endometriosis musical set for Edinburgh Fringe stage FemTech World
Published: July 31, 2026, 1:03 p.m.
Medicus Pharma receives UAE approval for endometriosis study - Investing.com
Medicus Pharma receives UAE approval for endometriosis study Investing.com
Published: July 31, 2026, 11:46 a.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - Quiver Quantitative
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix Quiver Quantitative
Published: July 31, 2026, 11:40 a.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - quiverquant.com
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix quiverquant.com
Published: July 31, 2026, 11:40 a.m.
Medicus Pharma receives UAE approval for endometriosis study By Investing.com - Investing.com Canada
Medicus Pharma receives UAE approval for endometriosis study By Investing.com Investing.com Canada
Published: July 31, 2026, 11:39 a.m.
Link copied to clipboard!